PARANEOPLASTIC DERMATOMYOSITIS

PARANEOPLASTIC DERMATOMYOSITIS was reported 93 times

PARANEOPLASTIC DERMATOMYOSITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 25 0.0003
1 Phenothiazine [EPC] 5 0.0002
2 Human Immunoglobulin G [EPC] 3 0.0001
3 Microtubule Inhibitor [EPC] 22 0.0001
4 Platinum-based Drug [EPC] 30 0.0001
5 Programmed Death Ligand-1 Blocker [EPC] 2 0.0001
6 Thiazide-like Diuretic [EPC] 3 0.0001
7 Androgen Receptor Inhibitor [EPC] 5 0.0001
8 Topoisomerase Inhibitor [EPC] 5 0.0001
9 Leukocyte Growth Factor [EPC] 8 0.0001
10 Vascular Endothelial Growth Factor Inhibitor [EPC] 10 0.0001
11 Nucleoside Metabolic Inhibitor [EPC] 13 0.0000
12 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
13 HER2/neu Receptor Antagonist [EPC] 3 0.0000
14 Provitamin D2 Compound [EPC] 1 0.0000
15 Estrogen [EPC] 5 0.0000
16 Aromatase Inhibitor [EPC] 3 0.0000
17 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
18 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
19 Corticosteroid [EPC] 24 0.0000
20 Factor Xa Inhibitor [EPC] 5 0.0000
21 Osmotic Laxative [EPC] 5 0.0000
22 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
23 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
24 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
25 Acetylcholine Release Inhibitor [EPC] 1 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 11 0.0000
27 Alkylating Drug [EPC] 2 0.0000
28 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
29 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
31 Kinase Inhibitor [EPC] 2 0.0000
32 Platelet Aggregation Inhibitor [EPC] 2 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
35 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
36 Loop Diuretic [EPC] 1 0.0000